When this happens, sugar (glucose) builds up in the blood. This can lead to serious medical problems.
The main goal of treating diabetes is to lower your blood sugar to a normal level. High blood sugar can be lowered by diet and exercise, and by certain medicines when necessary.
This Patient Information has been approved by the U. S. Food and Drug Administration.
Distributed by:
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, CT 06877 USA
Marketed by:
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, CT 06877 USA
and
Eli Lilly and Company
Indianapolis, IN 46285 USA
Licensed from:
Boehringer Ingelheim International GmbH
Ingelheim, Germany
*The brands listed are trademarks of their respective owners and are not trademarks of Boehringer Ingelheim Pharmaceuticals, Inc. The makers of these brands are not affiliated with and do not endorse Boehringer Ingelheim Pharmaceuticals, Inc., or its products.
Copyright 2011 Boehringer Ingelheim International GmbH
ALL RIGHTS RESERVED
IT5253AD2911
10007261/01
IT5437AD2911
10007237/01
Revised May 2011
TRADJENTA (linagliptin) 30 Tablets
NDC: 0597-0140-30
TRADJENTA (linagliptin) 1000 Tablets
NDC: 0597-0140-10
TRADJENTA (linagliptin) 7 Tablets
v NDC: 0597-0140-70
TRADJENTA (linagliptin) 90 Tablets
NDC: 0597-0140-90
